Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Extended transgene expression from a nonintegrating adenoviral vector containing retroviral elements.

Zheng C, Vitolo JM, Zhang W, Mineshiba F, Chiorini JA, Baum BJ.

Mol Ther. 2008 Jun;16(6):1089-97. doi: 10.1038/mt.2008.56. Epub 2008 Mar 25.

PMID:
18388914
[PubMed - indexed for MEDLINE]
2.

Strategies for targeting lentiviral vectors.

Frecha C, Szécsi J, Cosset FL, Verhoeyen E.

Curr Gene Ther. 2008 Dec;8(6):449-60. Review.

PMID:
19075628
[PubMed - indexed for MEDLINE]
3.

Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35.

Sakurai F.

Biol Pharm Bull. 2008 Oct;31(10):1819-25. Review.

PMID:
18827334
[PubMed - indexed for MEDLINE]
Free Article
4.

Advances in helper-dependent adenoviral vector research.

Segura MM, Alba R, Bosch A, Chillón M.

Curr Gene Ther. 2008 Aug;8(4):222-35. Review.

PMID:
18691018
[PubMed - indexed for MEDLINE]
5.

Transcriptional targeting to brain cells: Engineering cell type-specific promoter containing cassettes for enhanced transgene expression.

Boulaire J, Balani P, Wang S.

Adv Drug Deliv Rev. 2009 Jul 2;61(7-8):589-602. doi: 10.1016/j.addr.2009.02.007. Epub 2009 Apr 23. Review.

PMID:
19394380
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk